Curaleaf Holdings Files 6-K, Will Use Form 40-F

Ticker: CURLF · Form: 6-K · Filed: 2025-06-16T00:00:00.000Z

Sentiment: neutral

Topics: reporting, compliance, foreign-private-issuer

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on June 16, 2025, indicating it will file its annual report under Form 40-F. The filing includes a press release and another document as exhibits. The company's principal executive office is located in Vancouver, British Columbia, Canada.

Why It Matters

This filing signals Curaleaf's compliance with reporting requirements for Canadian companies listed in the US, providing an update on their regulatory filings.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming the form type for their annual report.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, and in this instance, it indicates that Curaleaf Holdings, Inc. will file its annual reports under cover of Form 40-F.

Which form will Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. will use Form 40-F for its annual reports, as indicated by the checkmark next to 'Form 40-F' in the filing.

When was this Form 6-K filed?

This Form 6-K was filed on June 16, 2025.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

What are the included exhibits with this filing?

The filing includes Exhibit 99.1, a Press Release, and Exhibit 99.2, which is another document.

From the Filing

0001756770-25-000021.txt : 20250616 0001756770-25-000021.hdr.sgml : 20250616 20250616124006 ACCESSION NUMBER: 0001756770-25-000021 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250616 FILED AS OF DATE: 20250616 DATE AS OF CHANGE: 20250616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251049163 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover061625.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: June 16, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release 99.2 Report of Voting Results EX-99.1 2 pressreleasevotingresults2.htm EX-99.1 Document Curaleaf Reports on Voting Results from the 2025 Annual General Meeting of Shareholders   STAMFORD, Conn., June 13, 2025 -- The annual general meeting of shareholders of Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, was held today via live webcast online (the "Meeting"). Each of the matters voted upon at the Meeting is discussed in detail in the Company's management information circular dated April 29, 2025 (the "Circular"), which can be found under the Company's profile on SEDAR+ (www.sedarplus.ca) and on EDGAR (https://www.sec.gov/edgar). The total number of votes cast by the shareholders in person or represented by proxy at the Meeting was 1,722,745,691 votes (with each subordinate voting share entitling the holder thereof to one (1) vote, and each multiple voting share entitling the holder thereof to fifteen (15) votes). The voting results in relation to the election of directors were as follows: Percentage of Votes Name of Director For (%) Withheld (%) Michelle Bodner 99.93 0.07 Karl Johansson 98.91 1.19 Boris Jordan 97.92 2.08 Mitchell Kahn 97.92 2.08 Joseph Lusardi 97.98 2.02 Shasheen Shah 99.92 0.08 In addition, the number of directors of the Company was also set by the shareholders of Curaleaf at ten (10) directors, and the resolution with respect to the reappointment of PKF O'Connor Davies, LLP as the Company's auditor put before the shareholders for consideration and approval at the Meeting, as described in the Circular, was duly approved by the requisite number of votes. The Company has filed a report of voting results on all resolutions voted on at the Meeting under its profile on www.sedarplus.ca and on www.sec.gov/edgar. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (

View on Read The Filing